SHORT-DURATION OF DIRECT-ACTING ANTIVIRALS IN CANCER PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

被引：0
|
作者：
Yibirin, Marcel [1 ]
Yepez-Guevara, Eduardo [1 ]
Granwehr, Bruno [1 ]
Pundhir, Pooja [1 ]
Torres, Harrys A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
936
引用
收藏
页码：573A / 574A
页数：2
相关论文
共 50 条
  • [31] Editorial: direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection
    Sanagapalli, S.
    Danta, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (04) : 536 - +
  • [32] Multimodal Treatment of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antivirals
    Mercan-Stanciu, Adriana
    Isac, Teodora
    Rababoc, Razvan
    Rusie, Daniel
    Toma, Letitia
    Vacaroiu, Ileana Adela
    Tulin, Raluca
    Iliescu, Elena Laura
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [33] Impact of Direct-Acting Antivirals Adherence on Cure Rate in Chronic Hepatitis C Virus
    Turcu-Stiolica, A.
    Doica, I. P.
    Ungureanu, B. S.
    Rogoveanu, I
    Subtirelu, M. S.
    Gheonea, D., I
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (01)
  • [34] Direct-acting antivirals for chronic hepatitis C virus genotype 5 and 6 infections
    Torres, Maria Corina Plaz
    Lleo, Ana
    Aghemo, Alessio
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (01): : 5 - 6
  • [35] Hepatic fibrosis changes in patients with chronic hepatitis C infection who respond to direct-acting antivirals
    Alswat, Khalid
    Al-Sohaibani, Fahad
    Khathlan, Abdullah
    Bashmail, Ahmad
    Alanazi, Mohammed
    Kurdi, Amr
    Almakadma, Abdul Hakim
    Al-Hamoudi, Waleed
    ANNALS OF SAUDI MEDICINE, 2022, 42 (02) : 89 - 95
  • [36] Delayed decrease of splenic stiffness in chronic hepatitis C virus patients receiving direct-acting antivirals
    Attia, D.
    Deterding, K.
    Cornberg, J.
    Manns, M. P.
    Gebel, M. J.
    Cornberg, M.
    Wedemeyer, H.
    Potthoff, A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S236 - S236
  • [37] BUDGET IMPACT ANALYSIS OF NOVEL DIRECT-ACTING ANTIVIRALS FOR TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION IN TAIWAN
    Kuo, W. J.
    Lin, C. L.
    Lang, H. C.
    VALUE IN HEALTH, 2019, 22 : S207 - S207
  • [38] Persistent perturbation of the circadian clock by chronic hepatitis C virus infection following cure with direct-acting antivirals
    Juhling, Frank
    Mukherji, Atish
    Mailly, Laurent
    Eller, Carla
    Ponsolles, Clara
    Herzog, Katharina
    Hamdane, Nourdine
    Zhuang, Xiaodong
    Aikata, Hiroshi
    Imamura, Michio
    Holmes, Jacinta
    Wang, Shu-Chi
    Yu, Ming-Lung
    Chung, Raymond
    Schuster, Catherine
    Felli, Emanuele
    Pessaux, Patrick
    McKeating, Jane
    Chayama, Kazuaki
    Baumert, Thomas
    JOURNAL OF HEPATOLOGY, 2021, 75 : S780 - S780
  • [39] Drug-Drug Interactions Potential of Direct-Acting Antivirals for the treatment of Chronic Hepatitis C Virus infection
    Neant, Nadege
    Solas, Caroline
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
  • [40] Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection
    Sicras-Mainar, Antoni
    Morillo-Verdugo, Ramon
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (10)
12345